CLOs on the Move

Vision Service Plan Global

www.vspglobal.com

 
At VSP Global, we activate the full power of care by consciously reinvesting in greater vision, health, and opportunities for all. Our mission is to help people see every possibility—and we do that through our strategic business pillars that work together to connect nearly 90 million patients to network doctors in a variety of settings across the globe. When you become a VSPeep, you join a group of thinkers, doers, adventurers, risk-takers, and boundary pushers who think outside the peripheral to develop products, programs, and services that help create a world where everyone can bring their best vision to life. ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.vspglobal.com
  • 3333 Quality Drive
    Rancho Cordova, CA USA 95670
  • Phone: 916.851.5000

Executives

Name Title Contact Details
Thomas Fessler
 Chief Legal Officer and General Counsel Profile
Christine Warren
 Chief Legal Officer and General Counsel Profile

Similar Companies

Radiancy, Inc.

Radiancy, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Orangeburg, NY. To find more information about Radiancy, Inc., please visit www.radiancy.com

Freedom Designs

Freedom Designs is a Simi Valley, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Visiting Nurse Service

Visiting Nurse Service is a Northport, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Northeast Monitoring Inc

Northeast Monitoring Inc is a Maynard, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.